Annual Information Update

Ardana PLC
28 September 2006

Ardana plc

28 September 2006


                                   Ardana plc
                                (the 'Company')

                           Annual Information Update


This annual information update is filed pursuant to Prospectus Rule 5.2 made by
the Financial Services Authority and not for any other purpose and by filing
this annual information update neither the Company, nor any other person, takes
any responsibility for, or makes any representation, express or implied, as to
the accuracy or completeness of, the information contained or referred to below
herein. The information referred to below is not necessarily up to date as at
the date of this annual information update and the Company does not undertake
any obligation to update any such information in the future. Furthermore, such
information may have been prepared in accordance with the laws or regulations of
a particular jurisdiction and may not comply with or meet the relevant standards
of disclosure in any other jurisdiction. Neither this annual information update,
nor the information referred to below constitutes, by virtue of this
communication, an offer of any securities addressed to any person and should not
be relied on by any person.


(1) Announcements made via a Regulatory Information Service


Date                      Brief description

20 September 2006         Announcement of proposed Placing and Open Offer of New Ordinary Shares

13 September 2006         Notification of submission to UK Listing Authority of Annual Report & Accounts

11 September 2006         Announcement of results in clinical trial for Testosterone Cream

07 September 2006         Announcement of results in clinical trial for Teverelix Long Acting in endometriosis

31 August 2006            Notice of grant of US patent

29 June 2006              Preliminary Results Announcement for the year ended 31 March 2006

29 June 2006              Appointment of Non-Executive Director

14 June 2006              Notification of Preliminary Results

16 May 2006               Announcement of holding in company

12 May 2006               Announcement of holding in company

03 May 2006               Announcement of application for block listing

12 April 2006             Announcement of results in clinical trial for Testosterone Cream

17 March 2006             Appointment of VP Sales & Marketing

16 March 2006             Announcement of holding in company

14 March 2006             Announcement of holding in company

31 January 2006           Update from meeting with US Food & Drug Administration for Testosterone Cream

13 December 2005'         Announcement of Interim Financial Results for the six months ended 30 September 2005

09 November 2005          Announcement of agreement with Nordic partner for Striant(TM) SR

31 October 2005           Announcement of results in clinical trial for Testosterone Cream

28 October 2005           Announcement of holding in company

05 October 2005           Announcement of launch of Striant(TM) SR in Germany



Copies of the above announcements can be downloaded from the Company's pages of
the London Stock Exchange website (www.londonstockexchange.com).


(2) Documents filed at Companies House


All of the documents listed below were filed with Companies House on or around
the dates indicated.


Date                      Brief description

27 July 2006              Appointment of Director

01 December 2005          Annual Return made up to 10 November 2005

15 November 2005          Form 288c change of director's particulars



Copies of documents filed at Companies House are available at Companies House
whose website address is www.companieshouse.gov.uk or at the following address
Companies House, Crown Way, Maindy, Cardiff CF14 3UZ.



(3) Documents published or sent to shareholders or filed with the UKLA Viewing 
    Facility


Date                      Brief description

20 September 2006         Proposed Placing and Open Offer, and Notice of
                          Extraordinary General Meeting

13 September  2006        Annual Report and Accounts for the ended 31 March 2006

13 September  2006        Letter to Shareholders and Notice of
                          Annual General Meeting

Copies of all the above the documents can be obtained from the Company 
Secretary.


For further information contact:

Graham Lee

Company Secretary

Tel. No. 0131 226 8550

Ardana plc

38 Melville Street

Edinburgh EH3 7HA

     

                      This information is provided by RNS
            The company news service from the London Stock Exchange